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The first COVID-19 case in Nepal was reported on January 23, 2020. Then infection,
then, started to spread gradually, and October marked the most devastating increase
in COVID-19 cases of the year 2020. Compared with the October 2020 peak in
Nepal, the May 2021 peak of COVID-19 observed 2- and 10-fold rise in new cases
and deaths per day, respectively. Given that this surprising increase in the death rate
was not observed in other countries, this study analyzed the COVID-19 case fatality
rates between the two peaks in Nepal. We found an increase in death rates among
younger adults and people without comorbidities.
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1 | INTRODUCTION
Nepal reported its first COVID-19 case on January 23, 2020, within
2 months of the global index case identified in China. Two additional
months were required for the second case to be diagnosed.1 Immedi-
ately after the second case, Nepal started to take stern measures to
tackle COVID-19. One of the most crucial management strategies
Nepal took was imposing the national level lockdowns, which were
relaxed and strengthened as the number of new cases reduced or
started to rise again, respectively, evident from three incidences of an
increase in COVID-19 infection during the span of a year (Figure 1A).
Early epidemiological analysis of deaths attributed to COVID-19
showed that, as opposed to many countries, Nepal had a relatively
lower case fatality rate (CFR) of 0.34%. In addition, females were
more likely to die from the disease than their male counterparts.2 An
understanding of the disease situation at the national level, followed
by identifying high-risk populations for SARS-CoV-2 infection and
fatality, holds significant implications for developing and executing
progressive public health surveillance and mitigation actions in Nepal.
This research aimed to analyze COVID-19 infection progression dur-
ing the two most recent infection peaks observed in Nepal.
2 | MATERIALS AND METHODS
We used the epidemiological data published by the Ministry of
Health and Population (MoHP), Nepal,3 and the World Health
Organization4 to calculate confirmed cases and fatality rates and
compare the public health impact of COVID-19. To calculate the
differences of CFR between two different peaks from additional
countries that displayed peak patterns similar to that of Nepal, we
downloaded the data from a public repository maintained at
ourworldindata.5 The numerator used to calculate CFR was the
total number of fatalities with 14-day lag time.6 To perform the
comparative analysis of the spike protein, we used the genome
sequences of the Nepalese SARS-CoV-2 strains and the Wuhan-1
strain available in National Center for Biotechnology Information
(NCBI).
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3 | RESULTS
The analysis of COVID-19 infection and death showed that Nepal had
three independent peaks of infection. The most recent peak occurred
during April to June 2021, overwhelmed health care institutions and
was the most devastating spell, with average infections and deaths
accounting for 9000 and 200 per day, respectively (Figure 1A). This
report analyzed the cases and deaths from the 6-week time frames of
Peaks 2 and 3. When we compared the number of cases and deaths
between the most recent and preceding peaks, we found that the
number of deaths increased by 10-fold. In contrast, number of cases
increased by about less than 3-fold, indicating a significant increase in
the CFR. Next, we aimed to identify the most vulnerable population
during the most recent peak. Therefore, we analyzed all the deaths in
terms of age, sex, and comorbidities. A total of 123,502 cases,
699 deaths, and 275,402 cases, 5103 deaths, were reported during
the second and third peaks, respectively. Although the number of
fatalities with known comorbidities relatively decreased, suggesting a
significant rise in fatality among the healthy population, the detailed
analysis of comorbid conditions and their link to death was impossible
due to the lack of data (Figure 1B). While there was not a big differ-
ence between sex-specific and age-specific morbidities within the
peaks, in Peak 3, the male had relatively higher mortality. Besides, the
CFR had also increased across most age strata, and we found a
remarkable rise in CFR among the younger age groups of 35–
64 years. This indicated that the younger population is still vulnerable
to disease in Nepal.
Genetic variants of SARS-CoV-2, through mutation, have
occurred over time. To identify the link between the occurrence of
SARS-CoV-2 variants and an increase in the number of incidence and
deaths in Nepal, we first analyzed the publicly available genome
sequence data for genomic surveillance. Although Nepal lacks in the
F I GU R E 1 Situation analysis of COVID-19 case fatality rate in Nepal. (A) Seven-day moving average of the daily COVID-19 infections (black)
and deaths (blue). The number of days of second and third peaks used for the analysis in this manuscript are shown by cyan fill and blue lines for
cases and deaths, respectively. (B) Confirmed cases and deaths attributed to COVID-19 during two independent 6-week durations highlighted in
Figure (A). Data are taken from the official situation reports of the Ministry of Health and Population, Nepal, and WHO Nepal Situation Report on
COVID-19. bCase fatality rate during a specific period was calculated as the total number of deaths/total number of cases during the same time
frame preceding 2 weeks. An * indicates death with any known comorbidity
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field of genomic epidemiology, researchers have attempted to
sequence and perform genomic epidemiological analysis of the SARS-
CoV-2 genome identified in Nepal.7 Besides, the government of
Nepal has also received significant support from the World Health
Organization in this issue.3 Compared with the Wuhan-1 strain, at
least six mutations in the spike protein were identified in Nepal
(Figure 2A). Furthermore, the genomic analysis performed during the
second quarter of 2021 showed the presence of alpha (B.1.1.7), kappa
(B.1.617.1), and delta (B.1.617.2) variants in Nepal. Among them, delta
variant was the most prevalent, with an overall prevalence of more
than 95%.3 Given that the alpha variant was first identified in the
United Kingdom much earlier than the kappa and delta variants were
identified in India,8 the predominance of delta variant in Nepal is also
correlated with the higher transmissibility. Furthermore, nearly 20%
of the delta variants spreading across Nepal had an additional K417N
mutation in the spike protein.
To examine the link between the SARS-CoV-2 variants preva-
lent in Nepal and the death rates, we first identified and analyzed
the reports from the countries that displayed a similar two-phase
peak of COVID-19 infection. We found that an increase in positivity
ratio was a factor responsible for the rise in number of cases
between the peaks and the situation in Nepal was not an uncom-
mon one (Figure 2B). Next, we analyzed the CFR between the two
peaks of these nations and found that Nepal had the highest
(227%) increase in the CFR between the peaks. With the most pre-
dominant delta variant, India reported an increase of more than
200% cases, but only about 10% increase in CFR during the most
recent peak. This indicated that the delta variant alone may not be
responsible for the increase in deaths in Nepal. Next, we aimed to
examine if the overwhelmed increase in infection cases was a factor
and found that both the increase in positivity and the number of
cases did not explain the rise in CFR in Nepal (Figure 2C,D). These
results indicated that some unknown factors might have played a
role in the increase.
4 | DISCUSSION
In summary, we performed a comparative analysis of the COVID-19
infections and deaths during the two most recent peaks in Nepal. We
also compared the data from Nepal with the countries that recently
displayed two similar peaks. Although Nepal had increased the num-
ber of daily tests, the increase in percentage positivity among tested
individuals was the major factor in the increase in cases. This could be
attributed to the relatively slower growth in the number of tests per-
formed than the rise in the number of cases. When available, the
COVID-19 tests were limited to targeted testing of symptomatic
patients and risk populations. We found that the delta variant was
F I GU R E 2 Evolutionary analysis and causal relationship of case fatality rate (CFR) in Nepal. (A) NCBI accession number, sample collection
date, lineage, and sequence alignment of the 11 spike proteins from Nepalese SARS-CoV-2 strains, with publicly available genome sequence and
comparison with the Wuhan-1 strain. UA, unassigned lineage. (B) Relationship between a change in positivity rate and the number of cases.
(C) Relationship between a change in positivity and CFR. Data include 25 countries that reported test positivity results and had two recent
infection peaks similar to Nepal (B, C). (D) Relationship between a change in the number of cases and CFR among 38 countries with two recent
infection peaks similar to Nepal. A blue arrow indicates Nepal’s position in the figures (B–D), and the detailed dataset is available as the
supporting information dataset
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widespread during the most recent peak in Nepal. Although this vari-
ant has an increased transmission capacity, higher hospitalization, sec-
ondary attack rates, and increased infection rates in younger groups,
its CFR was reported to be relatively lower9,10; in Nepal, the CFR
increased nearly three-fold. Although this might be attributed to the
poor health care system in Nepal, further studies are required to iden-
tify the reason more specifically. As Nepal’s death rate remained
lower during the early phase of infection,2 the recent rapid increase in
fatality rate is of serious concern. Besides, there is a possibility of
unidentified and unreported cases at the community level,
potentially leading to new epicenters. Likewise, the slow rate of
vaccine inoculation across regions also imperils the outbreak of future
infections.
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